EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
31/07/2026
Voltar para busca
Dado oficial do USPTO
MONJUVI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
04/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
10/08/2018
Data de registro
14/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/07/2026
Última transação
04/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Wilmington, DE, US
Examinador
INGOLD, GERALDINE
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
INCYTE HOLDINGS CORPORATION
MorphoSys AG
Representantes
Keith Toms, Esq. McCarter & English, LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorderscancerinflammatory diseasesrestenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorderscancerinflammatory diseasesrestenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorderscancerinflammatory diseasesrestenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorderscancerinflammatory diseasesrestenosis; diagnostic preparations for medical or veterinary purposes biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorderscancerinflammatory diseasesrestenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorderscancerinflammatory diseasesrestenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders
Classe 42
Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design servicesscientific researchanalysistesting services in the fields of analytical chemistrybiochemistrymedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistrybiochemistrymedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disordersinfectious diseasescancerinflammatory diseasesAlzheimersepsisrestenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
31/07/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
31/07/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31/07/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/07/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
31/07/2026
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
14/07/2026
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
14/07/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/07/2026
E815
TEAS SECTION 8 & 15 RECEIVED
10/04/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/06/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/06/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/06/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/05/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
24/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
14/04/2020
TMBN
TTAB RELEASE CASE TO TRADEMARKS
07/03/2020
OP.T
OPPOSITION TERMINATED NO. 999999
07/03/2020
OP.D
OPPOSITION DISMISSED NO. 999999
07/03/2020
OP.I
OPPOSITION INSTITUTED NO. 999999
13/01/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
20/11/2019
APET
ASSIGNED TO PETITION STAFF
18/11/2019
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
22/10/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
22/07/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/07/2019
PUBO
PUBLISHED FOR OPPOSITION
16/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/06/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/06/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/06/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/12/2018
GNRT
NON-FINAL ACTION E-MAILED
04/12/2018
CNRT
NON-FINAL ACTION WRITTEN
04/12/2018
DOCK
ASSIGNED TO EXAMINER
28/11/2018
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
20/11/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
15/11/2018
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
18/09/2018
ALIE
ASSIGNED TO LIE
18/09/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/08/2018
NWAP
NEW APPLICATION ENTERED
14/08/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MONJUVI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.